BioArctic AB (publ) (STO: BIOA.B)
Sweden
· Delayed Price · Currency is SEK
157.70
+0.10 (0.06%)
Oct 4, 2024, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 88 employees as of December 31, 2023. The number of employees increased by 27 or 44.26% compared to the previous year.
Employees
88
Change (1Y)
27
Growth (1Y)
44.26%
Revenue / Employee
3.12M SEK
Profits / Employee
-919.58K SEK
Market Cap
13.94B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca PLC | 89,900 |
Swedish Orphan Biovitrum AB (publ) | 1,772 |
Getinge AB (publ) | 11,739 |
Sectra AB (publ) | 1,204 |
Camurus AB (publ) | 213 |
Medicover AB (publ) | 45,316 |
Elekta AB (publ) | 4,718 |
AddLife AB (publ) | 2,301 |
BioArctic AB News
- 5 weeks ago - Study results from phase 1 studies with exidavnemab published in The Journal of Clinical Pharmacology - PRNewsWire
- 6 weeks ago - Leqembi (lecanemab) authorized for early Alzheimer's disease in Great Britain - PRNewsWire
- 6 weeks ago - Regarding rumors of an imminent approval of lecanemab in Great Britain: BioArctic - PRNewsWire
- 6 weeks ago - Invitation to presentation of BioArctic's second quarter report for April - June 2024 on August 29 at 9.30 a.m. CET - PRNewsWire
- 7 weeks ago - Leqembi approved for the treatment of Alzheimer's disease in the United Arab Emirates - PRNewsWire
- 2 months ago - Leqembi revenue more than doubled - totaled JPY 6.3 billion in the second quarter 2024 - PRNewsWire
- 2 months ago - Long-term lecanemab data show increased patient benefit with maintained safety profile - PRNewsWire
- 2 months ago - Eisai will seek re-examination of CHMP opinion för lecanemab - PRNewsWire